NEOS Investment Management’s Cullinan Oncology CGEM Stock Holding History

NEOS Investment Management’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-37,519	Closed	-$388K	–	593
2025 Q4	$388K	Buy	+37,519	New	+$338K	﹤0.01%	626
2025 Q3	–	Sell	-42,692	Closed	-$321K	–	634
2025 Q2	$321K	Buy	42,692 +3,528	+9%	+$28.3K	﹤0.01%	579
2025 Q1	$296K	Buy	39,164 +10,731	+38%	+$103K	0.01%	556
2024 Q4	$346K	Buy	28,433 +2,793	+11%	+$40.1K	0.01%	546
2024 Q3	$429K	Buy	25,640 +1,617	+7%	+$28.7K	0.01%	510
2024 Q2	$419K	Buy	24,023 +7,635	+47%	+$163K	0.02%	482
2024 Q1	$279K	Buy	16,388 +482	+3%	+$7.45K	0.02%	502
2023 Q4	$162K	Buy	+15,906	New	+$141K	0.02%	506

Other funds holding CGEM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return